Royalty Pharma plc

NASDAQ:RPRX

36.46 (USD) • At close July 3, 2025
Bedrijfsnaam Royalty Pharma plc
Symbool RPRX
Munteenheid USD
Prijs 36.37
Beurswaarde 20,450,497,775
Dividendpercentage 2.89%
52-weken bereik 24.05 - 36.46
Industrie Biotechnology
Sector Healthcare
CEO Mr. Pablo Gerardo Legorreta
Website https://www.royaltypharma.com

An error occurred while fetching data.

Over Royalty Pharma plc

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research

Vergelijkbare Aandelen

Seagen Inc. logo

Seagen Inc.

SGEN

228.74 USD

DexCom, Inc. logo

DexCom, Inc.

DXCM

82.93 USD

Biogen Inc. logo

Biogen Inc.

BIIB

132.87 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

547.01 USD

Align Technology, Inc. logo

Align Technology, Inc.

ALGN

196.82 USD

Hologic, Inc. logo

Hologic, Inc.

HOLX

64.78 USD

ICON Public Limited Company logo

ICON Public Limited Company

ICLR

150.1 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)